- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02177097
Chronic Pain, Inflammation and Infection After Joint Replacement
Extended Biochemical Analysis and Bacteriologic Diagnosis in Patients With Loose Joint Replacements, Chronic Pain and Infection.
Revision surgery after total hip or knee arthroplasty is an ongoing issue due to an increasing number of primary surgeries. Patients seek physicians due to pain. The cause is divided between loosening, infection or chronic pain. Some are operated on the suspicion of a chronic infection. However, postoperative microbiological testing does not always correlate with the suspicion and the operation may have been superfluous.
The objective is to employ a highly advanced diagnostic algorithm based on state of the art diagnostic techniques in order to improve the basis of preoperative diagnosis. Through this approach treatment can be given according to the causal problem.
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of the project is to improve the preoperative diagnosis of infections and persistent pain in patients with prosthesis-related problems. Prosthesis infection is of chronic nature. Recent research has shown that one important explanation of this is the formation of encapsulated 'bacterial communities' on the surface of the prosthesis, where bacteria are well protected against antibiotic treatment. Surgery is therefore necessary for this patient group. But it is important to make diagnosis more accurate than it currently is today. In contrast, patients with persistent pain, but no indication of infection or prosthetic loosening, are best served by avoiding surgery, and instead receiving a treatment that is directed against the chronic pain condition. Based on the pain research carried out at Aalborg University, an understanding of chronic pain and treatment principles that would be beneficial for this patient group have been developed.
The investigators want to:
- describe the postoperative course of specific serologic markers for primary and secondary total hip arthroplasty (THA) and total knee arthroplasty (TKA).
- describe the bacteriologic diversity through revision of THA and TKA using cultivation techniques and molecular biological analysis comprehensive fluorescence in-situ hybridization (FISH), cloning and phylogeny, quantitative polymerase chain reaction (qPCR) and gene expression profiling.
- describe pain and sensitization with new diagnostic technology in patients with stem loosening, suffering from infection and pain.
- apply to a new diagnostic algorithm for the diagnosis of infection and pain following THA and TKA, which includes pain assessment, diagnostic X-ray, bone scintigraphy, PET scan, percutaneous biopsy, specific serologic parameters and molecular biological analysis.
- describe the effect of the diagnostic algorithm, compared with a descriptive retrospective cohort of patients who have undergone revision of THA or TKA.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Northern Orthopaedic Division, Aalborg University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients undergoing primary uncemented total hip-joint replacement surgery
- Patients undergoing primary hybrid total hip-joint replacement surgery
- Patients undergoing total knee-joint replacement surgery
Exclusion Criteria:
- Patients younger than 18 years old
- Unability to speak or read Danish
- Pregnancy or lactating
- Bilateral disease
- Cancer
- Inability to give informed consent
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
40 patients (uTHA)
Patients undergoing primary uncemented total hip arthroplasty surgery.
|
4 x 10 ml blood samples.
|
40 patients (hTHA)
40 patients undergoing primary hybrid total hip replacement surgery.
|
4 x 10 ml blood samples.
|
40 patients (TKA)
40 patients undergoing total knee replacement surgery.
|
4 x 10 ml blood samples.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Examination of blood test parameters
Time Frame: 4 years
|
The outcome measure is a composite. In order to predict the risk of developing a serious infection we want to:
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Collect systematic data
Time Frame: 4 years
|
The outcome measure is a composite.
We want to collect systematic collect systematic data with a view to identify which specific blood parameters can best predict the risk that the patient develops a serious infection.
Furthermore, we want to collect systematic data with a view to optimize the diagnostic algorithm.
|
4 years
|
Generate a knowledge base
Time Frame: 4 years
|
The outcome measure is a composite.
We want to generate a knowledge base for optimal antibiotic treatment, optimal pain management, optimal treatment of infection and pain caused by THA and TKA.
|
4 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sten Rasmussen, M.D., Northern Orthopaedic Division, Aalborg University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-20110022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Joint Prosthesis
-
University of ZurichCompletedScheker Total Distal Radioulnar Joint ProsthesisSwitzerland
-
Assistance Publique - Hôpitaux de ParisUnknownHealth Education, Joint Prosthesis, Breast ImplantsFrance
-
Georgia Institute of TechnologyEmory University; Stryker OrthopaedicsTerminatedProsthesis User | Joint Disease | Ankle ArthroplastyUnited States
-
Alberta Hip and Knee ClinicUniversity of CalgaryNot yet recruitingInfection of Total Hip Joint Prosthesis | Infection of Total Knee Joint Prosthesis
-
Pherecydes PharmaRecruitingInfection of Total Hip Joint Prosthesis | Infection of Total Knee Joint ProsthesisFrance
-
The Cleveland Clinic3MCompletedJoint Diseases | Musculoskeletal Diseases | Prosthesis-related Infections | Wound ComplicationsUnited States
-
Frederiksberg University HospitalCompletedProsthesis Survival | Articular Bearing Surface Wear of Prosthetic Joint | Wear of Articular Bearing Surface of Prosthetic Joint
-
Rutgers, The State University of New JerseyTerminated
-
Vastra Gotaland RegionGöteborg UniversityRecruitingProsthetic Joint Infection | Hip Prosthesis Infection | Prosthetic Infection | Knee Prosthesis InfectionSweden
-
Bezmialem Vakif UniversityUnknownProsthesis-Related Infections | Joint Infection | Hip Prosthesis Infection | BiofilmTurkey
Clinical Trials on Blood samples
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Centre Georges Francois LeclercCompleted
-
Centre Hospitalier Universitaire de NīmesCompletedHenoch Schönlein PurpuraFrance
-
Centre Hospitalier Universitaire DijonCompletedPrimary Immune Thrombocytopenia (ITP)France
-
Institut BergoniéUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPaediatric MalignanciesFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
University Hospital, BordeauxRecruitingSystemic Sclerosis | SclerodermaFrance
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Assistance Publique Hopitaux De MarseilleRecruitingPlastic SurgeriesFrance